The COST Action CINNAMON CA24115 is dedicated to expanding, harmonising, and strengthening CAR-T cell therapy expertise across Europe.
By linking academic manufacturers, clinicians, researchers, regulators, patient organisations, and industry stakeholders, CINNAMON aims to accelerate innovation, ensure equitable access, and build the foundations for decentralised CAR‑T manufacturing.
Our network brings together centres from across Europe and beyond, working collaboratively to share knowledge, develop standards, foster training, and create a robust ecosystem for advanced cellular immunotherapies.
Explore our Working groups
CINNAMON is composed of six Working Groups (WGs) that will work on the implementation of the Action.
WG1:
Manufacturing, scale-up,
standardization and
quality control
WG2:
Preclinical development
of novel CAR-T therapies
WG3:
Regulatory affairs and
market access
WG4:
Clinical research
WG5:
Public awareness and
patient engagement
WG6:
Training and
dissemination
What’s New
STSM Grant applications are open for Grant Period 1 (1 March – 30 June 2026)
CINNAMON is pleased to announce the opening of the [...]
1st CINNAMON Meeting: Connecting an International Network of Academic Manufacturers of Oncoimmunotherapies
On 14 January 2026, the 1st meeting of the [...]
